基因诊断公司GeneDx Holdings（股票代码：WGS）今日盘中股价出现大幅下跌，跌幅达5.16%，引发市场关注。这一走势与多家华尔街分析机构最新发布的研究报告形成鲜明对比。
据悉，包括BTIG、杰富瑞和TD Cowen在内的多家知名投资银行均上调了GeneDx Holdings的目标股价。BTIG将目标价从140美元上调至165美元，杰富瑞从120美元上调至150美元，而TD Cowen则从140美元上调至165美元。这些目标价的上调反映了分析师对公司未来发展前景的看好。
然而，尽管分析师给出了积极评价，GeneDx Holdings的股价仍然出现大幅下跌。这种反差可能反映了市场对公司短期业绩或整体市场环境的担忧。投资者可能正在权衡分析师的长期乐观预期与当前市场波动之间的关系。在缺乏其他具体消息的情况下，股价下跌的原因可能涉及更广泛的市场因素或投资者情绪变化。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.